Research support technician Neuroscience

at  Universit du Luxembourg

The University of Luxembourg is an international research university with a distinctly multilingual and interdisciplinary character.
The Luxembourg Centre for Systems Biomedicine (LCSB) is an interdisciplinary research centre of the University of Luxembourg.
We conduct fundamental and translational research in the field of Systems Biology and Biomedicine – in the lab, in the clinic and in silico. We focus on neurodegenerative processes and are especially interested in Alzheimer’s and Parkinson’s disease and their contributing factors. The LCSB recruits talented scientists from various disciplines: computer scientists, mathematicians, biologists, chemists, engineers, physicists and clinicians from more than 50 countries currently work at the LCSB. We excel because we are truly interdisciplinary, and together we contribute to science and society.
We are looking for a qualified candidate open to work in a multidisciplinary team to reinforce the research team in the Translational Neuroscience (TN) group, headed by Prof. Dr. med. Rejko KRÜGER. We seek a lab technician for a 1-year position, with an immediate start. The candidate will be involved in performing experimental work using patient-based cellular models of neurodegenerative diseases, including cellular and molecular analyses for the functional investigation of intracellular signalling pathways.
Our research
The Translational Neuroscience team’s focus lies in the identification of new biomarkers and therapeutic targets for Parkinson’s disease (PD), aimed at bridging the gap between fundamental research and clinical research by embedding the “bed to bench to bedside” research approach. Fundamental research focuses on induced pluripotent stem cell (iPSC)-derived neuronal models to elucidate the molecular and cellular alterations contributing to neurodegeneration in familial and idiopathic forms of PD, Dementia with Lewy bodies (DLB), atypical parkinsonism (e.g. PSP or MSA), and in amyotrophic lateral sclerosis (ALS). Newly discovered molecular targets and disease-associated cellular phenotypes are used as readouts in drug screening approaches, to identify molecules that, after in vitro and in vivo validation, could be potentially used in future intelligent clinical trials. The clinical research focus is part of the National Centre for Excellence in Research on Parkinson’s Disease (NCER-PD), an initiative originally funded by the Luxembourg National Research Fund (FNR).

We expect you to be involved in state-of-the-art experimental work to advance translational research supporting different projects with a broad spectrum of different methods and technical devices. You will be involved in the optimal organization of the laboratory in collaboration with the other technicians, the anticipation of the management of stocks and orders, the development of protocols set up in the laboratory.